HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory Friedman, MD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Holly Lindsay Md
Aurora, Colorado, United States
- Memorial Sloan Kettering
New York, New York, United States
- Upmc Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Sept 2025
- Primary completion
- 18 Dec 2025
- Completion
- 18 Dec 2025
- Last update posted
- 10 Feb 2026
- Registered enrollment
- 0
- Registry id
- NCT04482933
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.